Login / Signup

Adverse Gastrointestinal Events With Sodium Polystyrene Sulfonate Use in Patients on Maintenance Hemodialysis: An International Cohort Study.

Ana Cecilia Farfan RuizRanjeeta MalickEmily RhodesEdward G ClarkGregory L HundemerAngelo KaraboyasBruce RobinsonRoberto PecoitsManish M Sood
Published in: Canadian journal of kidney health and disease (2023)
Sodium polystyrene sulfonate use in patients on hemodialysis was not associated with a higher risk of an adverse GI event. Our findings suggest that SPS use is safe in an international cohort of maintenance hemodialysis patients.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • ejection fraction
  • newly diagnosed
  • patient reported outcomes
  • patient reported
  • adverse drug
  • drug induced